Savita Rangarajan

Publications

85 publications

Page 6 of 9

Consensus recommendations for the use of FEIBA^® in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery

S. Rangarajan,

S. Austin,

N. J. Goddard,

C. Négrier,

E. C. Rodriguez-Merchan,

D. Stephensen,

& T. T. Yee

, 2013 , Haemophilia , 19 (2) , 294--303

DOI: 10.1111/hae.12028

Type: article

Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization

Peter W Collins,

Elizabeth Chalmers,

Daniel P Hart,

Ri Liesner,

Savita Rangarajan,

Kate Talks,

Mike Williams,

& Charles R Hay

, 2013 , British Journal of Haematology , 160 (2) , 153--170

DOI: 10.1111/bjh.12091

Type: article

Will gene therapy trump factor treatment in hemophilia?

Savita Rangarajan,

& Louis Aledort

, 2013 , Expert Review of Hematology , 6 (1) , 43--48

DOI: 10.1586/ehm.12.70

Type: review

The incidence of factor VIII inhibitors in severe haemophilia a following a major product switch in the UK: a prospective controlled study in 1214 previously treated patients

C. R. M. Hay,

P. Collins,

B. Palmer,

R. Liesner,

E. Chalmers,

D. Hart,

S. Rangarajan,

K. Talks,

& M. Williams

, 2013 , Journal of Thrombosis and Haemostasis , 12 (11) , 9

Type: conference

Hum1an-cl rhFVIII effectively and safely prevents bleeding episodes in previously treated adult patients with severe haemophilia A

S. Knaub,

T. Lissitchkov,

K. Hampton,

S. Rangarajan,

J. Bichler,

& J. Oldenburg

, 2013 , Haemophilia , 19 (3) , 468

Type: conference

Ageing and hemophilia: whose problem is it?.

G. Robinson,

J. Schuster,

& S. Rangarajan

, 2012 , Haemophilia , 18 (7) , 9

Type: conference

Three dominant-negative mutations in factor XI-deficient patients

L. Dai,

S. Rangarajan,

& M. Mitchell

, 2011 , Haemophilia , 17 (5) , e919--922

DOI: 10.1111/j.1365-2516.2011.02519.x

Type: article

Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma

L. Dai,

D. Bevan,

S. Rangarajan,

B. Sørensen,

& M. Mitchell

, 2011 , Haemophilia , 17 , e944--e948

DOI: 10.1111/j.1365-2516.2011.02491.x

Type: article

Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom

Charles R M Hay,

Ben Palmer,

Elizabeth Chalmers,

Ri Liesner,

Rhona Maclean,

Savita Rangarajan,

Michael Williams,

& Peter W Collins

, 2011 , Blood , 117 (23) , 6367--6370

DOI: 10.1182/blood-2010-09-308668

Type: article

Acquired agranulocytosis and factor XI deficiency in association with thymoma

Yogesh Jethava,

Jayanthi Alamelu,

Savita Rangarajan,

Loic Lang-Lazdunski,

Jon van der Walt,

& Paul Fields

, 2011 , Journal of Clinical Oncology , 29 (20) , e604--6

DOI: 10.1200/JCO.2010.34.3707

Type: article

Dr Savita Rangarajan

Connect with Savita

Publications